Literature DB >> 24750414

Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortality.

Sara J Temple1, Peter T W Kim, Pablo E Serrano, Daniel Kagedan, Sean P Cleary, Carol-Anne Moulton, Ian D McGilvray, Steven Gallinger, Paul D Greig, Alice C Wei.   

Abstract

BACKGROUND: Combined pancreaticoduodenectomy (PD) and colonic resection may be necessary to achieve an R0 resection of peri-ampullary tumours. The aim of this study was to examine the morbidity and mortality associated with this procedure.
METHODS: A retrospective cohort study was performed comparing 607 patients who underwent a standard pancreaticoduodenectomy (S-PD) to 28 patients who had a concomitant colon resection and PD (PD-colon) over a 10-year period at an academic centre.
RESULTS: Patients in the PD-colon group were more likely to have received neoadjuvant chemotherapy ± radiation (3/28, 11% versus 14/607, 2%, P = 0.024). Operative time was also longer (530 versus 410 min, P < 0.001) and they were more likely to have had portal vein resections (9/28, 32% versus 76/607, 13%, P = 0.007). There was no difference in the intra-operative blood loss, length of stay, or overall complication rates. The PD-colon group had a higher rate of severe post-operative bleeding (4/28, 11% versus 8/607, 1%, P = 0.002). The post-operative mortality rates for the PD-colon and PD groups were 2/28 (7%) and 8/607 (1%), respectively (P = 0.068).
CONCLUSIONS: PD-colon has an acceptable risk of peri-operative morbidity compared with S-PD in well-selected patients.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 24750414      PMCID: PMC4159451          DOI: 10.1111/hpb.12263

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  21 in total

1.  Evaluation of the International Study Group of Pancreatic Surgery definition of delayed gastric emptying after pancreatoduodenectomy in a high-volume centre.

Authors:  T Welsch; M Borm; L Degrate; U Hinz; M W Büchler; M N Wente
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

Review 2.  Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review.

Authors:  Terence C Chua; Akshat Saxena
Journal:  J Gastrointest Surg       Date:  2010-04-09       Impact factor: 3.452

3.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  THE RATIONALE OF RADICAL SURGERY FOR CANCER OF THE PANCREAS AND AMPULLARY REGION.

Authors:  A O Whipple
Journal:  Ann Surg       Date:  1941-10       Impact factor: 12.969

5.  En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Authors:  Aaron R Sasson; John P Hoffman; Eric A Ross; Steven A Kagan; James F Pingpank; Burton L Eisenberg
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

6.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Long-term survival in patients with locally advanced colon cancer after en bloc pancreaticoduodenectomy and colectomy.

Authors:  Akio Saiura; Junji Yamamoto; Masashi Ueno; Rintaro Koga; Makoto Seki; Norihiro Kokudo
Journal:  Dis Colon Rectum       Date:  2008-05-03       Impact factor: 4.585

8.  Additional organ resection combined with pancreaticoduodenectomy does not increase postoperative morbidity and mortality.

Authors:  Mehrdad Nikfarjam; Mandeep Sehmbey; Eric T Kimchi; Niraj J Gusani; Serene Shereef; Diego M Avella; Kevin F Staveley-O'Carroll
Journal:  J Gastrointest Surg       Date:  2009-02-07       Impact factor: 3.452

9.  Aberrant right hepatic artery in pancreaticoduodenectomy for adenocarcinoma: impact on resectability and postoperative outcomes.

Authors:  Peter T W Kim; Sara Temple; Eshetu G Atenafu; Sean P Cleary; Carol-Anne Moulton; Ian D McGilvray; Steven Gallinger; Paul D Greig; Alice C Wei
Journal:  HPB (Oxford)       Date:  2013-06-19       Impact factor: 3.647

10.  Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?

Authors:  Margo Shoup; Kevin C Conlon; David Klimstra; Murray F Brennan
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  9 in total

1.  Indication for en bloc pancreatectomy with colectomy: when is it safe?

Authors:  Patrick B Schwartz; Alexandra M Roch; Jane S Han; Alex V Vaicius; William P Lancaster; E Molly Kilbane; Michael G House; Nicholas J Zyromski; C Max Schmidt; Atilla Nakeeb; Eugene P Ceppa
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

2.  Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors.

Authors:  Abhishek Mitra; Esha Pai; Rohit Dusane; Priya Ranganathan; Ashwin DeSouza; Mahesh Goel; Shailesh V Shrikhande
Journal:  Langenbecks Arch Surg       Date:  2018-01-23       Impact factor: 3.445

3.  A pooled analysis of en bloc right hemicolectomy with pancreaticoduodenectomy for locally advanced right-sided colon cancer.

Authors:  Debang Li; Xiaoying Si; Tao Wan; Yanming Zhou
Journal:  Int J Colorectal Dis       Date:  2018-03-02       Impact factor: 2.571

Review 4.  Pancreatoduodenectomy associated with colonic resections: indications, pitfalls, and outcomes.

Authors:  Tommaso Giuliani; Anthony Di Gioia; Stefano Andrianello; Giovanni Marchegiani; Claudio Bassi
Journal:  Updates Surg       Date:  2021-02-13

5.  The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy.

Authors:  Daniel J Kagedan; Nik Goyert; Qing Li; Lawrence Paszat; Alexander Kiss; Craig C Earle; Paul J Karanicolas; Alice C Wei; Nicole Mittmann; Natalie G Coburn
Journal:  J Gastrointest Surg       Date:  2017-01-05       Impact factor: 3.452

6.  Pancreaticoduodenectomy for Retroperitoneal Sarcomas: A Mono-Institutional Experience in China.

Authors:  Cheng-Peng Li; Zhen Wang; Bo-Nan Liu; Ang Lv; Dao-Ning Liu; Jian-Hui Wu; Hui Qiu; Chun-Yi Hao
Journal:  Front Oncol       Date:  2020-09-23       Impact factor: 6.244

7.  Increased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomy: an NSQIP propensity-score matched analysis.

Authors:  Jennifer W Harris; Jeremiah T Martin; Erin C Maynard; Patrick C McGrath; Ching-Wei D Tzeng
Journal:  HPB (Oxford)       Date:  2015-07-30       Impact factor: 3.647

Review 8.  Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management.

Authors:  Adithya M Pathanki; Joseph A Attard; Elizabeth Bradley; Sarah Powell-Brett; Bobby V M Dasari; John R Isaac; Keith J Roberts; Nikolaos A Chatzizacharias
Journal:  World J Gastrointest Pathophysiol       Date:  2020-04-12

Review 9.  Pancreaticoduodenectomy for locally advanced colon cancer in hereditary nonpolyposis colorectal cancer.

Authors:  Rebecca Zhu; Gabriella Grisotti; Ronald R Salem; Sajid A Khan
Journal:  World J Surg Oncol       Date:  2016-01-15       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.